El Dr. Mohssen Ansarin es oncólogo especializado en cáncer de cabeza y cuello y es miembro fundador de SRS y AIOCC. Es autor y coautor de más de 50 artículos, y actualmente es el editor en jefe de ACTA Otolaryngologica.
Mostrar másEl Dr. Mohssen Ansarin es oncólogo especializado en cáncer de cabeza y cuello y es miembro fundador de SRS y AIOCC. Es autor y coautor de más de 50 artículos, y actualmente es el editor en jefe de ACTA Otolaryngologica.
Filippo de Marinis es Director de la Unidad de Oncología Torácica del Centro Europeo del Cáncer (Milán, Italia). El médico dirige ensayos clínicos de nuevos métodos en el tratamiento de tumores malignos del tórax.
La experiencia del médico es de más de 30 años.
En 1978, de Marinis completó sus estudios de neumología en la Universidad Sapienza de Roma. Entre 1983 y 1986 se especializó en oncología en la Universidad Católica del Sagrado Corazón de Roma. Después, Filippo de Marinis trabajó como médico en el Hospital Carlo Forlanini y en el Instituto de Ensayos Clínicos e Investigaciones Neumofisiológicas. Desde 2007, enseña neumología en la universidad privada de Roma “Campus Biomedico” (“Campus Biomedico”) y en la Universidad Sapienza de Roma. Desde 2013, el profesor es el jefe del Departamento de Cáncer Torácico del Centro Europeo del Cáncer.
Una cita con Filippo de Marinis dura de 40 a 60 minutos. Durante este tiempo, el médico recopila el historial médico del paciente y lo compara con los resultados del examen. Para establecer un diagnóstico preciso o planificar una operación, el médico prescribirá pruebas adicionales si es necesario.
El profesor de Marinis es autor de 250 publicaciones científicas en 130 publicaciones médicas. Como uno de los mejores especialistas en el tratamiento del cáncer de pulmón, ha sido ponente en 300 congresos científicos en los últimos 5 años.
El médico participa en ensayos clínicos nacionales e internacionales de nuevos medicamentos.
Filippo de Marinis es Director de la Unidad de Oncología Torácica del Centro Europeo del Cáncer (Milán, Italia). El médico dirige ensayos clínicos de nuevos métodos en el tratamiento de tumores malignos del tórax.
La experiencia del médico es de más de 30 años.
En 1978, de Marinis completó sus estudios de neumología en la Universidad Sapienza de Roma. Entre 1983 y 1986 se especializó en oncología en la Universidad Católica del Sagrado Corazón de Roma. Después, Filippo de Marinis trabajó como médico en el Hospital Carlo Forlanini y en el Instituto de Ensayos Clínicos e Investigaciones Neumofisiológicas. Desde 2007, enseña neumología en la universidad privada de Roma “Campus Biomedico” (“Campus Biomedico”) y en la Universidad Sapienza de Roma. Desde 2013, el profesor es el jefe del Departamento de Cáncer Torácico del Centro Europeo del Cáncer.
Una cita con Filippo de Marinis dura de 40 a 60 minutos. Durante este tiempo, el médico recopila el historial médico del paciente y lo compara con los resultados del examen. Para establecer un diagnóstico preciso o planificar una operación, el médico prescribirá pruebas adicionales si es necesario.
El profesor de Marinis es autor de 250 publicaciones científicas en 130 publicaciones médicas. Como uno de los mejores especialistas en el tratamiento del cáncer de pulmón, ha sido ponente en 300 congresos científicos en los últimos 5 años.
El médico participa en ensayos clínicos nacionales e internacionales de nuevos medicamentos.
Barbara Alicia Erechek es Directora del Departamento de Radioterapia del Centro Europeo del Cáncer en Milán y Profesora de Oncología Radioterápica en la Universidad de Milán. El médico se especializa en radioterapia para todo tipo de cáncer y tumores metastásicos.
La profesora Erechek recibió su título de médico en la Universidad de Gdansk (Polonia) en 1992. Mejoró sus calificaciones en el campo de la oncología radioterápica en el Instituto Oncológico de Varsovia, la Universidad de Milán, el Centro de Cáncer Beatson en la Universidad de Glasgow (Reino Unido). Desde 1997, el médico trabaja como especialista en radioterapia en el Centro Europeo del Cáncer. Desde 2015, es la jefa del departamento de radioterapia de la clínica.
Una cita con el Dr. Erechek para la planificación de la radioterapia tarda entre 30 y 50 minutos. El médico examina los registros médicos del paciente y los resultados de las pruebas. Ella explica el diagnóstico, habla sobre cómo se llevará a cabo el tratamiento posterior. El médico da recomendaciones sobre la mejor manera de prepararse para el curso de los procedimientos para que sean más cómodos.
Para obtener una consulta del profesor Erechek, deje una solicitud en el sitio web de Bookimed. El coordinador médico se pondrá en contacto con usted para acordar la fecha y hora de la consulta.
La profesora Bárbara Alicia Erechek es autora de 140 publicaciones científicas.
Entre 1999 y 2003, el Prof. Jereczek recibió 4 premios de la Universidad Médica de Gdańsk por investigaciones en el campo de la oncología y la radioterapia.
Barbara Alicia Erechek es Directora del Departamento de Radioterapia del Centro Europeo del Cáncer en Milán y Profesora de Oncología Radioterápica en la Universidad de Milán. El médico se especializa en radioterapia para todo tipo de cáncer y tumores metastásicos.
La profesora Erechek recibió su título de médico en la Universidad de Gdansk (Polonia) en 1992. Mejoró sus calificaciones en el campo de la oncología radioterápica en el Instituto Oncológico de Varsovia, la Universidad de Milán, el Centro de Cáncer Beatson en la Universidad de Glasgow (Reino Unido). Desde 1997, el médico trabaja como especialista en radioterapia en el Centro Europeo del Cáncer. Desde 2015, es la jefa del departamento de radioterapia de la clínica.
Una cita con el Dr. Erechek para la planificación de la radioterapia tarda entre 30 y 50 minutos. El médico examina los registros médicos del paciente y los resultados de las pruebas. Ella explica el diagnóstico, habla sobre cómo se llevará a cabo el tratamiento posterior. El médico da recomendaciones sobre la mejor manera de prepararse para el curso de los procedimientos para que sean más cómodos.
Para obtener una consulta del profesor Erechek, deje una solicitud en el sitio web de Bookimed. El coordinador médico se pondrá en contacto con usted para acordar la fecha y hora de la consulta.
La profesora Bárbara Alicia Erechek es autora de 140 publicaciones científicas.
Entre 1999 y 2003, el Prof. Jereczek recibió 4 premios de la Universidad Médica de Gdańsk por investigaciones en el campo de la oncología y la radioterapia.
Professor Santoro is heavily involved in research, with interest in many topics, such as the development of new cancer drugs and new biological therapies, interests for solid and haematological tumours, and not only he treats cancer survivors but also patients with comorbidities.
He has worked in Humanitas Research Hospital for 22 years. Professor Santoro’s post-graduate research was carried out at the Unité de Development Therapeutique (Institut de Cancerologie et d’Immunogenetique, Villejuif of Paris) from 1974 to 1975, and in the Division of Medical Oncology of the National Cancer Institute of Milan from 1976 to 1977.
In 1977, he specialized in Clinical and Laboratory Haematology at University of Rome. In 1979, he completed his fellowship post-graduate work in the Memorial Sloan Kettering Cancer Center of New York and later, at Stanford University. In 1980, he specialized in oncology at the University of Genoa.
Current Teaching Activity: Professor Santoro worked as Contract Professor at the Specialization School in Clinical Pathology ad Pavia University from 1992 to 1997. Also, from 1993 to 2002 he has been President of the Rare Tumour Group. Now he is full professor at Humanitas University.
Current Positions:
In addition, Professor Santoro’s unique expertise was recognized through numerous awards, such as the Managing Doctor of the Year award (2013), the City of Siena S. Caterina d’Oro Award (2013, Serra Association Award for scientific research) and social and healthcare commitment (Salerno, 2009).
Publications: santoro%a - Search Results - PubMed (nih.gov)
Mostrar másProfessor Santoro is heavily involved in research, with interest in many topics, such as the development of new cancer drugs and new biological therapies, interests for solid and haematological tumours, and not only he treats cancer survivors but also patients with comorbidities.
He has worked in Humanitas Research Hospital for 22 years. Professor Santoro’s post-graduate research was carried out at the Unité de Development Therapeutique (Institut de Cancerologie et d’Immunogenetique, Villejuif of Paris) from 1974 to 1975, and in the Division of Medical Oncology of the National Cancer Institute of Milan from 1976 to 1977.
In 1977, he specialized in Clinical and Laboratory Haematology at University of Rome. In 1979, he completed his fellowship post-graduate work in the Memorial Sloan Kettering Cancer Center of New York and later, at Stanford University. In 1980, he specialized in oncology at the University of Genoa.
Current Teaching Activity: Professor Santoro worked as Contract Professor at the Specialization School in Clinical Pathology ad Pavia University from 1992 to 1997. Also, from 1993 to 2002 he has been President of the Rare Tumour Group. Now he is full professor at Humanitas University.
Current Positions:
In addition, Professor Santoro’s unique expertise was recognized through numerous awards, such as the Managing Doctor of the Year award (2013), the City of Siena S. Caterina d’Oro Award (2013, Serra Association Award for scientific research) and social and healthcare commitment (Salerno, 2009).
Publications: santoro%a - Search Results - PubMed (nih.gov)
Dr Braun's primary responsibilities include direct leadership and execution of complex surgeries, including gastric bypass, sleeve gastrectomy, and other advanced metabolic and bariatric procedures. He has developed solid experience in managing the different clinical challenges present in obese patients, providing them with personalized and optimized care to ensure positive long-term outcomes.
His surgical practice is based on an in-depth methodology and a careful look at the latest technological innovations in the field of bariatric surgery. He has actively worked to implement advanced protocols and continually improve operational techniques, while maintaining the highest standards of patient safety and care.
With over 2000 operations performed as a surgeon specializing in oncology, he has developed extensive experience and expertise in laparoscopic and robotic surgery applied to the care of cancer patients.
As a primary operator, he has successfully conducted a wide range of laparoscopic and robotic surgeries for the treatment of oncological conditions, including gastrointestinal, urological, gynecological and other solid tumors. His surgical practice has focused on the application of advanced techniques, using cutting-edge laparoscopic instruments and robotic systems
Mostrar másDr Braun's primary responsibilities include direct leadership and execution of complex surgeries, including gastric bypass, sleeve gastrectomy, and other advanced metabolic and bariatric procedures. He has developed solid experience in managing the different clinical challenges present in obese patients, providing them with personalized and optimized care to ensure positive long-term outcomes.
His surgical practice is based on an in-depth methodology and a careful look at the latest technological innovations in the field of bariatric surgery. He has actively worked to implement advanced protocols and continually improve operational techniques, while maintaining the highest standards of patient safety and care.
With over 2000 operations performed as a surgeon specializing in oncology, he has developed extensive experience and expertise in laparoscopic and robotic surgery applied to the care of cancer patients.
As a primary operator, he has successfully conducted a wide range of laparoscopic and robotic surgeries for the treatment of oncological conditions, including gastrointestinal, urological, gynecological and other solid tumors. His surgical practice has focused on the application of advanced techniques, using cutting-edge laparoscopic instruments and robotic systems
Prof. Filippini began his career in 1980 and has been teaching at the University of Chieti since the 1990s in the fields of General Surgery, Microsurgery, Reconstructive Surgery, Vascular Surgery, Orthopedics, and Gynecology. His primary focus is oncological surgery, particularly specializing in "The surgical treatment of locally advanced tumors and multi-organ resections." He has enriched his expertise by visiting prominent reference centers in the United States, including the Memorial Sloan Kettering Cancer Center in Manhattan, New York City. There, he delved into minimally invasive, laparoscopic, and microsurgical techniques under the guidance of esteemed mentors such as John Daly, Michele Gagner, and Murray Brennan. Additionally, in 2005, he further expanded his skills at the City of Hope Oncology Center in Los Angeles, focusing on robotic surgery in oncology.
In 1980, Prof. Filippini graduated in Medicine and Surgery from the G. D'Annunzio University of Chieti in Italy with honors, presenting an experimental thesis on lympho-venous anastomosis using microsurgical techniques. He completed his specialization in general surgery at the University of Pisa with distinction after five years. In 1990, he obtained another specialization in Plastic and Reconstructive Surgery from the University of Padua in Italy, where he maintained a stellar academic record.
Prof. Filippini has presented at numerous national and international conferences and authored over 100 scientific publications. Additionally, he has co-authored two monographs.
Mostrar másProf. Filippini began his career in 1980 and has been teaching at the University of Chieti since the 1990s in the fields of General Surgery, Microsurgery, Reconstructive Surgery, Vascular Surgery, Orthopedics, and Gynecology. His primary focus is oncological surgery, particularly specializing in "The surgical treatment of locally advanced tumors and multi-organ resections." He has enriched his expertise by visiting prominent reference centers in the United States, including the Memorial Sloan Kettering Cancer Center in Manhattan, New York City. There, he delved into minimally invasive, laparoscopic, and microsurgical techniques under the guidance of esteemed mentors such as John Daly, Michele Gagner, and Murray Brennan. Additionally, in 2005, he further expanded his skills at the City of Hope Oncology Center in Los Angeles, focusing on robotic surgery in oncology.
In 1980, Prof. Filippini graduated in Medicine and Surgery from the G. D'Annunzio University of Chieti in Italy with honors, presenting an experimental thesis on lympho-venous anastomosis using microsurgical techniques. He completed his specialization in general surgery at the University of Pisa with distinction after five years. In 1990, he obtained another specialization in Plastic and Reconstructive Surgery from the University of Padua in Italy, where he maintained a stellar academic record.
Prof. Filippini has presented at numerous national and international conferences and authored over 100 scientific publications. Additionally, he has co-authored two monographs.
Prof. Deraco has dedicated his career to helping patients with complex cancers, particularly those affecting the peritoneum, a membrane in the abdomen. He began his medical career in 1989 at the Surgery and Experimental Oncology Departments of the Fondazione IRCCS, National Cancer Institute in Milan, Italy. Over the years, he has played a key role in advancing treatments for peritoneal surface malignancies (PSM). For more than a decade, he was the lead physician for the Peritoneal Surface Malignancies Program. Since 2017, he has served as the director of the Peritoneal Surface Malignancies Unit, where he continues to focus on providing cutting-edge care for his patients.
Prof. Deraco’s expertise is in specialized cancer treatments like Cytoreductive Surgery (CRS), Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC), and Pressurized Intra-Peritoneal Aerosolized Chemotherapy (PIPAC). These techniques aim to remove cancer and deliver heated chemotherapy directly to the abdomen, giving patients with PSM new hope. He has successfully treated over 1,200 patients using these advanced methods.
In addition to his clinical work, Prof. Deraco is a professor at Milan University, where he teaches future surgeons about peritoneal surface malignancies. His teaching extends internationally, as he has mentored over 30 postdoctoral fellows from prestigious institutions worldwide.
Prof. Deraco’s educational background is extensive. He earned his medical degree from the University of Messina in 1987 with top honors, followed by a specialization in general surgery five years later. His training continued in Paris, where he specialized in oncology at the prestigious Paris Dauphine University. He further honed his skills through fellowships in world-renowned institutions such as the Gustave Roussy Institute in France, the Royal Marsden Hospital in the UK, and the Washington Cancer Institute in the USA.
Throughout his career, Prof. Deraco has remained actively involved in research and professional organizations. He has published over 250 scientific articles and 25 book chapters, contributing to the advancement of cancer treatment globally. He serves on the board of multiple scientific societies dedicated to cancer research, including the Peritoneal Surface Oncology International Group (PSOGI) and the Italian Society for Loco-Regional Cancer Therapy (SITILO).
Mostrar másProf. Deraco has dedicated his career to helping patients with complex cancers, particularly those affecting the peritoneum, a membrane in the abdomen. He began his medical career in 1989 at the Surgery and Experimental Oncology Departments of the Fondazione IRCCS, National Cancer Institute in Milan, Italy. Over the years, he has played a key role in advancing treatments for peritoneal surface malignancies (PSM). For more than a decade, he was the lead physician for the Peritoneal Surface Malignancies Program. Since 2017, he has served as the director of the Peritoneal Surface Malignancies Unit, where he continues to focus on providing cutting-edge care for his patients.
Prof. Deraco’s expertise is in specialized cancer treatments like Cytoreductive Surgery (CRS), Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC), and Pressurized Intra-Peritoneal Aerosolized Chemotherapy (PIPAC). These techniques aim to remove cancer and deliver heated chemotherapy directly to the abdomen, giving patients with PSM new hope. He has successfully treated over 1,200 patients using these advanced methods.
In addition to his clinical work, Prof. Deraco is a professor at Milan University, where he teaches future surgeons about peritoneal surface malignancies. His teaching extends internationally, as he has mentored over 30 postdoctoral fellows from prestigious institutions worldwide.
Prof. Deraco’s educational background is extensive. He earned his medical degree from the University of Messina in 1987 with top honors, followed by a specialization in general surgery five years later. His training continued in Paris, where he specialized in oncology at the prestigious Paris Dauphine University. He further honed his skills through fellowships in world-renowned institutions such as the Gustave Roussy Institute in France, the Royal Marsden Hospital in the UK, and the Washington Cancer Institute in the USA.
Throughout his career, Prof. Deraco has remained actively involved in research and professional organizations. He has published over 250 scientific articles and 25 book chapters, contributing to the advancement of cancer treatment globally. He serves on the board of multiple scientific societies dedicated to cancer research, including the Peritoneal Surface Oncology International Group (PSOGI) and the Italian Society for Loco-Regional Cancer Therapy (SITILO).